Related Experiment Video
Updated: Dec 22, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
CHA2DS2-VASc Score Predicts Adverse Outcome in Patients with Simple Congenital Heart Disease Regardless of Cardiac
Giorgio Faganello1, Giulia Barbati2, Giulia Russo3
1Azienda Sanitaria Universitaria Integrata di Trieste, Via Slataper n°9, 34134, Trieste, Italy. giorgio.faganello@libero.it.
Insights
The CHA2DS2-VASc score effectively predicts adverse events in adults with simple congenital heart disease (sACHD), regardless of their heart rhythm. This score helps stratify long-term clinical risks for this growing patient population.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease (ACHD)
Background:
- Adult patients with simple congenital heart disease (sACHD) are an increasing population at risk for atrial arrhythmias (AA).
- The CHA2DS2-VASc score is established for estimating thromboembolic risk in non-valvular atrial fibrillation.
Purpose of the Study:
- To evaluate the prognostic value of the CHA2DS2-VASc score in a broad sACHD population.
- To assess the score's utility irrespective of the patient's current cardiac rhythm.
Main Methods:
- A cohort of 427 sACHD patients (November 2009-June 2018) was analyzed.
- Patients were categorized by CHA2DS2-VASc score (0-1 vs. >1).
- Composite primary endpoint: cardiovascular hospitalization and/or all-cause death over a mean 70-month follow-up.
Main Results:
- Patients with CHA2DS2-VASc score >1 (Group B) were older and had more risk factors.
- The primary endpoint occurred in 22% of patients, significantly higher in Group B (37%) versus Group A (10%).
- CHA2DS2-VASc score independently predicted the primary endpoint in the overall cohort and in those with sinus rhythm.
Conclusions:
- The CHA2DS2-VASc score is a valuable tool for risk stratification in sACHD patients.
- Its prognostic capability extends to patients regardless of their cardiac rhythm, including those in sinus rhythm.
- The score aids in identifying sACHD patients at higher risk for long-term adverse clinical events.
Abstract:
Adult patients with simple congenital heart disease (sACHD) represent an expanding population vulnerable to atrial arrhythmias (AA). CHA2DS2-VASc score estimates thromboembolic risk in non-valvular atrial fibrillation patients. We investigated the prognostic role of CHA2DS2-VASc score in a non-selected sACHD population regardless of cardiac rhythm. Between November 2009 and June 2018, 427 sACHD patients (377 in sinus rhythm, 50 in AA) were consecutively referred to our ACHD service. Cardiovascular hospitalization and/or all-cause death were considered as composite primary end-point. Patients were divided into group A with CHA2DS2-VASc score = 0 or 1 point, and group B with a score greater than 1 point. Group B included 197 patients (46%) who were older with larger prevalence of cardiovascular risk factors than group A. During a mean follow-up of 70 months (IQR 40-93), primary end-point occurred in 94 patients (22%): 72 (37%) in group B and 22 (10%, p < 0.001) in group A. Rate of death for all causes was also significantly higher in the group B than A (22% vs 2%, respectively, p < 0.001). Multivariable Cox regression analysis revealed that CHA2DS2-VASc score was independently related to the primary end-point (HR 1.84 [1.22-2.77], p = 0.004) together with retrospective AA, stroke/TIA/peripheral thromboembolism and diabetes. Furthermore, CHA2DS2-VASc score independently predicted primary end-point in the large subgroup of 377 patients with sinus rhythm (HR 2.79 [1.54-5.07], p = 0.01). In conclusion, CHA2DS2-VASc score accurately stratifies sACHD patients with different risk for adverse clinical events in the long term regardless of cardiac rhythm.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies